التصنيف: anti-diabetic.secretagogues.sglt2 inhibitors المادة الفعالة:dapagliflozin+metformin
mechanism of action dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (sglt2) which are responsible for at least 90% of the glucose reabsorption in the kidney. blocking this transporter mechanism causes blood glucose to be eliminat
